Inhibition of Caffeine Metabolism by Estrogen Replacement Therapy in Postmenopausal Women
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
This study was conducted to investigate the effect of therapeutic estrogen on cytochrome P450 1A2‐mediated metabolism in postmenopausal women using caffeine as a model substrate. Twelve healthy postmenopausal women underwent estrogen replacement therapy in the form of estradiol (Estrace). Estradiol was initiated at a dose of 0.5 mg a day and titrated to achieve a steady‐state plasma concentration of 50 to 150 pg/ml. Caffeine metabolic ratios (CMR; paraxanthine/ caffeine) were assessed both before and after 8 weeks of estrogen replacement. For the 12 subjects, there was a mean reduction in CMR of −29.2 25.0 (p = 0.0019). Consistent with previous results found in younger women, these results indicate that exogenous estrogen in older women may inhibit CYP1A2‐mediated caffeine metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785 · cited 1×
“The CYP1A2 isozyme is a lower capacity isozyme than CYP3A4, making competitive inhibitory interactions between estrogen and CYP1A2 substrate drugs distinctly possible.(4) It is also of interest that systemic clearances of caffeine and theophylline, two typical CYP1A2 drugs, have been noted to be lower in the late lute…”
BackgroundImpairment of Caffeine Clearance by Chronic Use of Low-Dose Oestrogen-Containing Oral Contraceptives
Abernethy, D. R., & Todd, E. L. (1985) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544361 · Cited by 195
Menstrual cycle effects on caffeine elimination in the human female
Lane, J. D., Steege, J. F., Rupp, S. L., & Kuhn, C. M. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02285099 · Cited by 170
Cited by
Coffee and Health: A Review of Recent Human Research
Higdon, J. V., & Frei, B. (2006) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390500400009 · Cited by 1,090
Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Nehlig, A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014407 · Cited by 632
Pregnancy-Induced Changes in Pharmacokinetics: A Mechanistic-Based Approach
Anderson, G. D. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544100-00001 · Cited by 648
Inhibition and induction of human cytochrome P450 enzymes: current status
Pelkonen, O., Turpeinen, M., Hakkola, J., Honkakoski, P., Hukkanen, J., & Raunio, H. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0332-8 · Cited by 569
Coffee: Biochemistry and Potential Impact on Health
Ludwig, I. A., Clifford, M. N., Lean, M. E. J., Ashihara, H., & Crozier, A. (2014) · Food Funct. · doi:10.1039/c4fo00042k · Cited by 537
Metadata
- Authors
- Pollock, B. G., Wylie, M., Stack, J. A., Sorisio, D. A., Thompson, D. S., Kirshner, M. A., Folan, M. M., & Condifer, K. A.
- Venue
- The Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1999-09
- Volume
- 39
- Issue
- 9
- Pages
- 936-940
- ISSN
- 0021-9754 (ISSN-L)
- 0091-2700
- 1552-4604
- OpenAlex
- W2138893118
- Cited by
- 120
- References
- 3
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of Caffeine Metabolism by Estrogen Replacement Therapy in Postmenopausal Women. https://app.cochat.ai/papers/10.1177/00912709922008560
- The paper
- Pollock, B. G., Wylie, M., Stack, J. A., Sorisio, D. A., Thompson, D. S., Kirshner, M. A., Folan, M. M., & Condifer, K. A. (1999). Inhibition of Caffeine Metabolism by Estrogen Replacement Therapy in Postmenopausal Women. The Journal of Clinical Pharmacology. https://doi.org/10.1177/00912709922008560
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.